GenesisCare and PreludeDx Partnered to Form Precision Medicine Across the Globe
GenesisCare, a provider of the integrated cancer care across the globe announced that, it has been successful in taking a minority equity position in the company ‘Prelude Corporation (PreludeDx)’, which is a leader in the precision medicine and molecular diagnostics. The investment is now going to represent the second partnership for both the companies, and […]
Continue Reading